Menu
Not yet recruiting NCT07539168

Factors Affecting Immediate Anterior Implants Esthetics.

Observational Pink Esthetic Score Implant Survival Rate Immediate Implant Placement

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
This is an observational study: the protocol does not assign a study treatment.
Who it may be relevant to
Registry conditions: Pink Esthetic Score, Implant Survival Rate, Immediate Implant Placement. Basic parameters: 21 years — 55 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Factors Affecting Immediate Anterior Implants Esthetics . Clinical Retrospective Study

Overview

This retrospective cohort study evaluates clinical, surgical, and prosthetic factors associated with early and mid-term outcomes of immediate implant placement in the anterior maxilla. The primary objective is to identify predictors of implant survival and complications (e.g., infection, soft-tissue dehiscence, esthetic failure) within 12 months following placement. Secondary objectives include assessment of peri-implant marginal bone loss, prosthetic complications, and esthetic outcomes (pink esthetic score).

Detailed description

Study design:

Retrospective observational cohort study using existing patient records and radiographs from IDCE between September 2022 -March 2026. Data extraction will be performed blinded to outcome assessment.

Participants:

Subjects who received immediate implant placement in the anterior region (canine to canine) during the study period with at least 12 months follow-up. Expected sample size: approximately 500 patients/implants

Primary outcome measures

  • Pink esthetic score [Time frame: 3 years]

Eligibility criteria

Inclusion criteria

  • flapless immediately placed implants in esthetic zone with 3 years follow up CBCT,
  • presence of immediate postoperative CBCT,
  • initial intact thick gingival biotype with at least 2 mm band of keratinized tissue
  • thin intact labial bone plate (< 1mm) extending 7 mm apically assessed by CBCT with good apical bone
  • patients who had provided an informed consent.

Exclusion criteria

  • patients with medical conditions that would compromise the surgical procedures, uncontrolled diabetes mellitus, taking IV bis-phosphonates for treatment of osteoporosis
  • patients with active infection related at the site of implant and patients with untreated active periodontal diseases.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT07539168 · IDCE-31042026

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗